Glycemic Control Assessed by Intermittently Scanned Glucose Monitoring in Type 1 Diabetes during the COVID-19 Pandemic in Austria

被引:1
|
作者
Secco, Katharina [1 ]
Baumann, Petra Martina [1 ]
Poettler, Tina [1 ]
Aberer, Felix [1 ]
Cigler, Monika [1 ]
Elsayed, Hesham [1 ]
Harer, Clemens Martin [1 ]
Weitgasser, Raimund [2 ]
Schuetz-Fuhrmann, Ingrid [3 ,4 ]
Mader, Julia Katharina [1 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Endocrinol & Diabetol, Auenbruggerpl 15, A-8036 Graz, Austria
[2] Private Clin Wehrle Diakonissen, Dept Internal Med & Diabetol, A-5026 Salzburg, Austria
[3] Hosp Hietzing, Med Div Metab Dis & Nephrol 3, A-1130 Vienna, Austria
[4] Karl Landsteiner Inst, Inst Metab Dis & Nephrol, A-1130 Vienna, Austria
关键词
COVID-19; glycemic control; isCGM; lockdown; pandemic; type; 1; diabetes; CORONAVIRUS DISEASE 2019; IMPACT;
D O I
10.3390/s24144514
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Objective: The aim of this analysis was to assess glycemic control before and during the coronavirus disease (COVID-19) pandemic. Methods: Data from 64 (main analysis) and 80 (sensitivity analysis) people with type 1 diabetes (T1D) using intermittently scanned continuous glucose monitoring (isCGM) were investigated retrospectively. The baseline characteristics were collected from electronic medical records. The data were examined over three periods of three months each: from 16th of March 2019 until 16th of June 2019 (pre-pandemic), from 1st of December 2019 until 29th of February 2020 (pre-lockdown) and from 16th of March 2020 until 16th of June 2020 (lockdown 2020), representing the very beginning of the COVID-19 pandemic and the first Austrian-wide lockdown. Results: For the main analysis, 64 individuals with T1D (22 female, 42 male), who had a mean glycated hemoglobin (HbA1c) of 58.5 mmol/mol (51.0 to 69.3 mmol/mol) and a mean diabetes duration 13.5 years (5.5 to 22.0 years) were included in the analysis. The time in range (TIR[70-180mg/dL]) was the highest percentage of measures within all three studied phases, but the lockdown 2020 phase delivered the best data in all these cases. Concerning the time below range (TBR[<70mg/dL]) and the time above range (TAR[>180mg/dL]), the lockdown 2020 phase also had the best values. Regarding the sensitivity analysis, 80 individuals with T1D (26 female, 54 male), who had a mean HbA1c of 57.5 mmol/mol (51.0 to 69.3 mmol/mol) and a mean diabetes duration of 12.5 years (5.5 to 20.7 years), were included. The TIR[70-180mg/dL] was also the highest percentage of measures within all three studied phases, with the lockdown 2020 phase also delivering the best data in all these cases. The TBR[<70mg/dL] and the TAR[>180mg/dL] underscored the data in the main analysis. Conclusion: Superior glycemic control, based on all parameters analyzed, was achieved during the first Austrian-wide lockdown compared to prior periods, which might be a result of reduced daily exertion or more time spent focusing on glycemic management.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Glycemic control in type 1 diabetes during COVID-19 pandemic
    Secco, Katharina
    Ziko, Haris
    Poettler, Tina
    Hochfellner, Daniel
    Weitgasser, Raimund
    Schuetz-Fuhrmann, Ingrid
    Mader, Julia Katharina
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 220 - 220
  • [2] Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19
    Uchihara, Masaki
    Kodani, Noriko
    Bouchi, Ryotaro
    Saito, Sho
    Miyazato, Yusuke
    Sugimoto, Hirofumi
    Umamoto, Kotaro
    Kobayashi, Michi
    Ihana-Sugiyama, Noriko
    Ohsugi, Mitsuru
    Tanabe, Akiyo
    Ueki, Kohjiro
    Takasaki, Jin
    Hojo, Masayuki
    Kajio, Hiroshi
    GLOBAL HEALTH & MEDICINE, 2022, 4 (06): : 336 - 340
  • [3] Efficacy of unblinded and blinded intermittently scanned continuous glucose monitoring for glycemic control in adults with type 1 diabetes
    Guo, Lixin
    Li, Yuxiu
    Zhang, Mei
    Xiao, Xinhua
    Kuang, Hongyu
    Yang, Tao
    Jia, Xiaofan
    Zhang, Xianbo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes
    Leelarathna, Lalantha
    Evans, Mark L. L.
    Neupane, Sankalpa
    Rayman, Gerry
    Lumley, Sarah
    Cranston, Iain
    Narendran, Parth
    Barnard-Kelly, Katharine
    Sutton, Christopher J. J.
    Elliott, Rachel A. A.
    Taxiarchi, Vicky P. P.
    Gkountouras, Georgios
    Burns, Matthew
    Mubita, Womba
    Kanumilli, Naresh
    Camm, Maisie
    Thabit, Hood
    Wilmot, Emma G. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1477 - 1487
  • [5] Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes
    Cusinato, Maria
    Martino, Mariangela
    Sartori, Alex
    Gabrielli, Claudia
    Tassara, Laura
    Debertolis, Giulia
    Righetto, Elena
    Moretti, Carlo
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (09): : 1089 - 1093
  • [6] Type 1 diabetes mellitus and COVID-19: glycemic control before, during and after the pandemic
    Machado Guimaraes, E.
    Paiva Catalao, D.
    Guimaraes, D.
    Marques, M.
    Oliveira, A. P.
    Oliveira, R.
    Cardoso, A. F.
    Gama, E.
    Moleiro, P.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 216 - 216
  • [7] In type 1 diabetes, real-time vs. intermittently scanned continuous glucose monitoring improved glycemic control
    Olson, Darin E.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (10) : JC119 - JC119
  • [8] Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes
    Carolina Sousa
    João Sérgio Neves
    Cláudia Camila Dias
    Rute Sampaio
    Endocrine, 2023, 79 : 477 - 483
  • [9] Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes
    Sousa, Carolina
    Neves, Joao Sergio
    Dias, Claudia Camila
    Sampaio, Rute
    ENDOCRINE, 2023, 79 (03) : 477 - 483
  • [10] COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020
    Nwosu, Benjamin Udoka
    Al-Halbouni, Layana
    Parajuli, Sadichchha
    Jasmin, Gabrielle
    Zitek-Morrison, Emily
    Barton, Bruce A.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12